Viridian Therapeutics, Inc. VRDN
NASDAQ · United States · Health Technology
$18.99-1.60 (-7.77%)
Market closed· · USD · Data may be delayed
Prices may be delayed and are for informational purposes only - not investment advice.
Market closed· · USD · Data may be delayed
Prices may be delayed and are for informational purposes only - not investment advice.
| Quarter | Report date | Actual EPS | Estimated EPS | EPS surprise | Actual revenue | Revenue surprise | Price reaction |
|---|---|---|---|---|---|---|---|
| Q2 2026 | 2026-08-06 | -1.05 | -1.03 | -1.5% | $284.00K | +403.9% | +12.0%$21.07→$23.59 |
| Q1 2026 | 2026-05-05 | -0.90 | -1.06 | +15.1% | — | — | +24.7%$14.06→$17.53 |
| Q4 2025 | 2026-02-26 | -1.08 | -0.90 | -20.0% | — | — | +1.5%$28.94→$29.38 |
| Q3 2025 | 2025-11-05 | -0.34 | -0.82 | +58.5% | — | — | +22.0%$22.55→$27.50 |
| Q4 2023 | 2024-02-27 | -1.35 | -1.03 | -31.1% | — | — | — |
| Q3 2023 | 2023-11-13 | -1.09 | -1.24 | +12.1% | — | — | — |
The price reaction is the change from the last close before the announcement date to the first close after it - the report may land before the open, during the session or after the close, so this window covers all three. Not investment advice.